Valuation: Vivos Inc.

Market Cap 29.31M 25.74M 23.94M 21.97M 41.27M 2.82B 41.91M 284M 111M 1.39B 110M 108M 4.8B P/E 2024
-16.2x
P/E 2025 -10.2x
Enterprise Value 27.86M 24.47M 22.76M 20.88M 39.24M 2.68B 39.84M 270M 106M 1.32B 105M 102M 4.56B EV / Sales 2024
1,724x
EV / Sales 2025 438x
Free-Float
95.79%
Yield 2024 *
-
Yield 2025 -
1 day+1.09%
1 week-1.00%
Current month-3.10%
1 month-0.84%
3 months-15.29%
6 months-11.36%
Current year-13.93%
1 week 0.05
Extreme 0.0501
0.06
1 month 0.05
Extreme 0.0501
0.12
Current year 0.05
Extreme 0.0501
0.12
1 year 0.04
Extreme 0.0425
0.14
3 years 0.04
Extreme 0.0412
0.26
5 years 0.04
Extreme 0.04
0.26
10 years 0.01
Extreme 0.0065
8
Manager TitleAgeSince
Chief Executive Officer 79 14/12/2016
President 44 15/09/2025
Director of Finance/CFO 59 01/12/2018
Director TitleAgeSince
Chairman 81 14/12/2016
Director/Board Member 79 02/08/2017
Date Insider Type Main position Quantity % Market Cap.
22/07/26 Buy

Chairperson

32,000 0.0065%
15/07/26 Buy

Chief Executive Officer

200,000 0.0405%
30/06/26 Free

Chairperson

147,159 0.0298%
Change 5-day change 1-year change 3-year change Capi.($)
+1.09%-1.00%-54.73%-5.27% 29.31M
-3.58%-0.54%-19.93%-25.36% 13.29B
-0.07%+1.96%+43.11%-11.88% 3.94B
+0.67%-2.62%+67.77%+106.31% 1.21B
-3.46%-4.08%-44.11%-62.45% 1.14B
-1.62%-2.27%-42.56%-49.63% 1.07B
-3.98%-4.44%-47.66% - 900M
-3.75%-8.19%+20.45%+74.26% 450M
-1.67%-3.28%+62.25% - 324M
-1.90%-3.12%-59.62%+215.54% 257M
Average -1.83%-3.05%-7.50%+30.19% 2.26B
Weighted average by Cap. -2.61%-4.23%-6.16%-13.61%

Financials

2024 2025
Net sales 28K 24.59K 22.87K 20.98K 39.43K 2.7M 40.03K 272K 106K 1.33M 105K 103K 4.58M 68.38K 60.06K 55.85K 51.25K 96.3K 6.58M 97.78K 663K 259K 3.24M 257K 251K 11.19M
Net income -2.91M -2.56M -2.38M -2.18M -4.1M -280M -4.16M -28.23M -11.03M -138M -10.93M -10.69M -476M -3.07M -2.69M -2.5M -2.3M -4.32M -295M -4.38M -29.74M -11.62M -145M -11.51M -11.26M -502M
Net Debt -2.21M -1.94M -1.81M -1.66M -3.12M -213M -3.16M -21.46M -8.38M -105M -8.31M -8.13M -362M -1.44M -1.27M -1.18M -1.08M -2.03M -139M -2.07M -14.01M -5.47M -68.38M -5.42M -5.3M -236M
Logo Vivos Inc.
Vivos Inc. is a radiation oncology medical device company. The Company has developed an Yttrium-90-based injectable Precision Radionuclide Therapy medical device to treat tumors in animals (IsoPet) and humans (RadioGel). Using the Company’s proprietary hydrogel technology, PRnT uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows the safe delivery of higher doses needed for treating non-resectable and radiation-resistant cancers. University veterinary hospitals use the IsoPet Solutions division to demonstrate animal cancers’ safety and therapeutic effectiveness. RadioGel is a hydrogel liquid containing tiny yttrium-90 phosphate microparticles that may be administered directly into a tumor.
Employees
1
Date Price Change Volume
24/07/26 $0.0593 +1.09% 1,087,671
23/07/26 $0.0587 +1.15% 566,663
22/07/26 $0.0580 +10.24% 1,656,285
21/07/26 $0.0526 -9.29% 2,207,829
20/07/26 $0.0580 -3.12% 2,002,156
  1. Stock Market
  2. Stocks
  3. RDGL Stock